Despite constraints, Kenya remains the most advanced pharmaceutical manufacturer in East Africa and the third-largest exporter of pharmaceuticals on the continent.
By
Linet Owoko
Correspondent
Nation Media Group
When President William Ruto announced in October 2023 that at least 50 percent of medicines on the Kenya Essential Medicines List (KEML) would be manufactured locally by 2026, it gave hope to local pharmaceutical manufacturers who had struggled for many years to compete with cheaper imports and unreliable government payments.
Kenya in a drive to attain WHO medicine production level in the next five months
Govt eyes fast-tracking local production of high-end medical devices
Tanzania courts pharmaceutical investors at China industry forum
Kenya Nears a Critical Minerals Deal With the US on Its Own Terms
Kenya Nears a Critical Minerals Deal With the US to Process at Home
Kenyans eye tariff-free boom with Chinese market
US edges out China in Kenya with preliminary deal to control $62.4 billion untapped rare earth deposits
The economics behind Kenya’s pharmaceutical industry are shaping which medicines reach patients.
Kenya is ramping up efforts to attain the World Health Organization's (WHO) Maturity Level 3 (ML3) status in pharmaceutical…
The move opens a direct route for international providers, including those now setting up in Kenya, to bill into the country's…
Once listed, HIV commodities will be eligible for government budgeting, national quantification and pooled procurement through…
The funding boost comes at a critical moment for the State drug supplier, which has been grappling with cash flow constraints,…
Industry analysts estimate that around 75 percent of Kenyans are under 35 years old, indicating that demand is driven by…
